Arash Dabestani, Dean of the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, co-authored a groundbreaking study published in the Journal of Investigative Dermatology. The research, conducted with faculty from Yale University, found a substantial portion of acne and rosacea treatments currently on the market contain unacceptably high levels of benzene, a known human carcinogen.
